http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20015228-D0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2001-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8fd06a834cfdbd8afe443024cd70e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae0fb8ed700a702948662df4c5332fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_293d1e9d879599914dcc37195f6e67aa
publicationDate 2001-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20015228-D0
titleOfInvention Use of saredutant and its pharmaceutically acceptable salts for the manufacture of drugs used to treat or prevent mental disorders, adaptation disorders, or mixed anxiety-depression disorders
priorityDate 1999-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501615

Total number of triples: 24.